source
- Nascent US psychedelic therapy opportunity attracts overseas manufacturersCompanies that manufacture MDMA and psilocybin for patients in other countries are looking to use their experience to access the potential U.S. market.BioSpace · 26m ago↗ source
- Taiho and Cullinan report positive Phase 3 results for zipalertinib in EGFR exon 20 insertion lung cancerTaiho Oncology and Cullinan Therapeutics announced that their experimental drug zipalertinib achieved positive results in a Phase 3 trial for first‑line treatment of lung cancer patients whose tumo…